LUCE, Amalia
 Distribuzione geografica
Continente #
NA - Nord America 1.035
EU - Europa 1.027
AS - Asia 144
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.207
Nazione #
US - Stati Uniti d'America 1.027
IE - Irlanda 418
IT - Italia 205
GB - Regno Unito 107
DE - Germania 87
UA - Ucraina 75
SG - Singapore 53
CN - Cina 40
FR - Francia 33
GR - Grecia 28
FI - Finlandia 26
SE - Svezia 24
KR - Corea 18
TR - Turchia 11
BE - Belgio 10
CA - Canada 8
PK - Pakistan 8
NL - Olanda 5
VN - Vietnam 4
IN - India 3
TW - Taiwan 3
AT - Austria 2
CZ - Repubblica Ceca 2
ES - Italia 2
CH - Svizzera 1
EU - Europa 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
MD - Moldavia 1
Totale 2.207
Città #
Dublin 418
Chandler 335
Jacksonville 128
Bremen 47
Princeton 47
Roxbury 43
Caserta 42
New York 34
Medford 31
Singapore 29
Ann Arbor 25
Boardman 24
Naples 19
Cambridge 18
Des Moines 18
Beijing 17
Wilmington 17
Napoli 14
Seoul 13
Ashburn 10
Aversa 9
Brussels 9
Milan 9
San Mateo 9
Montréal 8
Rome 8
San Nicola la Strada 8
Woodbridge 8
Cava Dei Tirreni 7
Helsinki 6
Mountain View 5
Dong Ket 4
Los Angeles 4
Munich 4
Nottingham 4
Amsterdam 3
Bahawalpur 3
Campodarsego 3
Jinan 3
Parma 3
San Giorgio a Cremano 3
Scandiano 3
Taipei 3
Bascape 2
Berlin 2
Brno 2
Changchun 2
Düsseldorf 2
Falls Church 2
Forino 2
Hanover 2
Houston 2
Seattle 2
Taiyuan 2
Tianjin 2
Vienna 2
Washington 2
Xi'an 2
Auburn Hills 1
Bologna 1
Caiazzo 1
Capri 1
Capua 1
Catania 1
Centro 1
Cinisi 1
Clifton 1
Clifton Park 1
Delhi 1
Duncan 1
Edinburgh 1
Ferrara 1
Ferrol 1
Florence 1
Frankfurt am Main 1
Gricignano di Aversa 1
Guangzhou 1
Guidonia 1
Gunzenhausen 1
Hebei 1
Hyderabad 1
Jerusalem 1
Kish 1
Lahore 1
Lanciano 1
Lappeenranta 1
Lausanne 1
Limatola 1
Maddaloni 1
Madrid 1
Malmo 1
Nanjing 1
Norwalk 1
Nuremberg 1
Paris 1
Phoenix 1
Pomigliano d'Arco 1
Pozzuoli 1
Pune 1
Redwood City 1
Totale 1.527
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 90
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 88
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 77
Mitochondria as playmakers of apoptosis, autophagy and senescence 71
Tuberculous Lymphadenitis in Southern Italy: Clinical Aspects and Treatment Perspectives 67
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 67
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 64
Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review) 64
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 63
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 61
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 60
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 60
Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time? 56
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 54
Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network. 54
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 52
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 52
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 49
Basal Cell Carcinoma: Molecular and Pathological Features 48
Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience 48
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 48
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 46
Keratin 5 expression in squamocellular carcinoma of the head and neck. 45
Efficacy and Safety of Cetuximab plus Radiotherapy in Cisplatin-Unfit Elderly Patients with Advanced Squamous Cell Head and Neck Carcinoma: A Retrospective Study 44
Peptide functionalization of silicon for detection and classification of prostatic cells 42
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 41
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides. 41
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 41
Endocrine disruptors and female cancer: Informing the patients (Review) 39
KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer 39
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 39
Role of perineural invasion as a prognostic factor in laryngeal cancer 38
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 38
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 37
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 37
Autophagic cell death: A new frontier in cancer research 36
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 35
Treatment of c-kit positive adenoid cystic carcinoma of the tongue: A case report. 35
The role of micrornas in development of colitis-associated colorectal cancer 35
Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy? 33
Temporal bone meningioma involving the middle ear: A case report 31
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 31
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol 30
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 30
Evolution of mutational landscape and tumor immune-microenvironment in liver oligo-metastatic colorectal cancer 28
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 25
Polydatin Induces Differentiation and Radiation Sensitivity in Human Osteosarcoma Cells and Parallel Secretion through Lipid Metabolite Secretion 24
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 22
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 21
Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation 17
Immune cell infiltration and inflammatory landscape in primary brain tumours 17
Characterization of KRAS Mutational Regression in Oligometastatic Patients 15
On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer 14
Whey Improves In Vitro Endothelial Mitochondrial Function and Metabolic Redox Status in Diabetic State 10
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 9
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 3
Totale 2.361
Categoria #
all - tutte 10.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020185 0 24 7 34 20 1 36 24 12 9 10 8
2020/2021280 18 5 32 18 37 22 29 20 32 24 32 11
2021/2022307 10 6 4 4 88 10 14 5 17 28 19 102
2022/2023999 69 36 26 129 87 100 4 63 422 17 23 23
2023/2024318 25 15 30 11 87 41 7 5 0 3 23 71
2024/202534 16 18 0 0 0 0 0 0 0 0 0 0
Totale 2.361